{"gene":"HSPD1","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1998,"finding":"GroEL (HSP60) mediates protein folding through major asymmetric conformational changes driven by ATP binding and GroES co-chaperonin interaction. A nonnative polypeptide bound to one GroEL ring is encapsulated by GroES to form a cis ternary complex, initiating folding in a sequestered cavity; ATP hydrolysis in the cis ring primes product release, and subsequent ATP binding in the trans ring disrupts the cis complex, allowing the polypeptide to achieve its native state or recycle.","method":"Structural and biochemical reconstitution studies; crystal structures of GroEL-GroES complexes; in vitro ATPase and folding assays","journal":"Annual review of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple structural (crystallography) and biochemical reconstitution studies replicated across labs","pmids":["9759498"],"is_preprint":false},{"year":1990,"finding":"HSP60 monomers require pre-existing functional HSP60 complex for their own assembly into 14-mer double-ring complexes after import into mitochondria. In hsp60-defective yeast (mif4 mutant), newly imported wild-type subunits fail to assemble, demonstrating that self-assembly of HSP60 is catalyzed by existing HSP60 complex in an ATP-dependent process.","method":"Yeast genetic mutant (mif4), in vitro mitochondrial import assay, pulse-chase analysis of subunit assembly","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with mutant yeast and in vitro import assay, directly establishing autocatalytic assembly requirement","pmids":["1978929"],"is_preprint":false},{"year":2002,"finding":"The V72I (p.Val98Ile in updated nomenclature) missense mutation in human HSPD1 causes SPG13 hereditary spastic paraplegia. Wild-type HSP60 together with co-chaperonin HSP10 can complement E. coli cells lacking groEL/groES, but HSP60(V72I) cannot, demonstrating the mutation impairs essential chaperonin function.","method":"Genetic complementation assay in E. coli groES/groEL deletion strain; family linkage mapping","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional complementation assay directly testing mutant vs wild-type HSP60 chaperonin activity in vivo","pmids":["11898127"],"is_preprint":false},{"year":2007,"finding":"HSP60 is released from adult cardiac myocytes via the exosomal pathway. Within exosomes, HSP60 is tightly attached to the exosome membrane rather than being free in the lumen.","method":"Exosome isolation, Western blot, investigation of multiple secretion pathways including classical Golgi-mediated pathway","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, direct fractionation and pathway dissection experiment with functional consequence (non-classical secretion route identified)","pmids":["17307989"],"is_preprint":false},{"year":2007,"finding":"HSP60 regulates tumor cell apoptosis by stabilizing mitochondrial survivin and restraining p53 function. Acute siRNA ablation of HSP60 destabilizes mitochondrial survivin, induces mitochondrial dysfunction, disrupts an HSP60-p53 complex (leading to p53 stabilization), increases Bax expression, and activates caspase-dependent apoptosis.","method":"siRNA knockdown, high-throughput proteomics (co-IP screen), Co-immunoprecipitation, flow cytometry for apoptosis, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP identifying survivin and p53 as HSP60 partners, combined with functional KD showing specific apoptotic phenotype replicated with multiple readouts","pmids":["18086682"],"is_preprint":false},{"year":2005,"finding":"Cytosolic HSP60 in cardiac cells complexes with pro-apoptotic proteins Bax and Bak and with Bcl-XL, but not with Bcl-2. During hypoxia, HSP60 redistributes from cytosol to the plasma membrane. Reduction in HSP60 expression precipitates apoptosis without altering mitochondrial function, and HSP60 accelerates cleavage of pro-caspase-3.","method":"Co-immunoprecipitation, subcellular fractionation, siRNA knockdown, Western blot, live-cell imaging","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and fractionation in single lab, multiple binding partners identified with functional KD phenotype","pmids":["15784164"],"is_preprint":false},{"year":2008,"finding":"The SPG13-associated HSP60 mutation p.V98I (c.292G>A) reduces ATPase activity and strongly decreases capacity to refold denatured malate dehydrogenase in vitro. In a bacterial model lacking endogenous chaperonin genes, expression of Hsp60(V98I)/Hsp10 strongly inhibits cell growth. Co-expression of mutant and wild-type Hsp60 at low levels produces a dominant negative effect.","method":"In vitro ATPase assay, in vitro malate dehydrogenase refolding assay, bacterial complementation model with conditional gene expression, microarray analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (in vitro enzymatic assay, in vitro protein folding assay, bacterial in vivo model) in single study demonstrating mechanism of pathogenic mutation","pmids":["18400758"],"is_preprint":false},{"year":2009,"finding":"HSP60 interacts with beta-catenin through its apical domain, increases beta-catenin protein levels, and enhances beta-catenin transcriptional activity to promote metastasis. siRNA-mediated repression of beta-catenin reverts the metastatic activity caused by HSP60 overexpression. Proteasomal activity is not required for HSP60-induced beta-catenin increase.","method":"Co-immunoprecipitation, overexpression/siRNA knockdown, in vitro invasion assays, mouse in vivo metastasis model","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus epistasis (beta-catenin KD rescues phenotype), single lab","pmids":["19369584"],"is_preprint":false},{"year":2013,"finding":"Extracellular HSP60 induces inflammatory cytokine production in cardiomyocytes via TLR4-MyD88-p38-NF-κB pathway, and upregulates TLR2/4 expression via TLR4-MyD88-JNK-NF-κB pathway. During ischemia, endogenous HSP60 is released extracellularly and activates the same pathways.","method":"Exogenous HSP60 treatment of cardiomyocytes, siRNA/pathway inhibitors, in vivo rat LAD ligation model, ELISA, Western blot","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with multiple inhibitors and in vivo model, single lab","pmids":["23447644"],"is_preprint":false},{"year":2005,"finding":"HSP60 and mortalin (mtHsp70) physically interact both in vivo and in vitro, with the N-terminal region of mortalin involved in the interaction. They show co- and exclusive localizations in vivo, and both are involved in tumorigenesis, but mortalin (not HSP60) overexpression extends in vitro lifespan of normal fibroblasts.","method":"Co-immunoprecipitation, in vitro pulldown, shRNA knockdown, fluorescence microscopy co-localization, in vitro lifespan assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal in vivo and in vitro interaction assays, single lab, domain mapping","pmids":["15957980"],"is_preprint":false},{"year":2013,"finding":"The Hsp60 folding machinery is required for proper folding of manganese superoxide dismutase (MnSOD). Hsp60 and MnSOD physically interact. In heterozygous Hspd1 knockout mice (modeling SPG13), decreased Hsp60 leads to increased oxidative stress in neuronal tissues, attributed to impaired MnSOD folding.","method":"Heterozygous Hspd1 knockout mouse model, co-immunoprecipitation of Hsp60-MnSOD, oxidative stress measurements, enzyme activity assays","journal":"Free radical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO model with Co-IP demonstrating substrate interaction and functional consequence, single lab","pmids":["24151936"],"is_preprint":false},{"year":2010,"finding":"Homozygous inactivation of Hspd1 (gene-trap insertion) causes early embryonic lethality in mice at days 6.5–7.5 post-implantation, demonstrating that Hsp60 is essential for early embryonic development. Heterozygous mice survive normally with reduced Hsp60 and Hsp10 protein levels.","method":"Gene-trap mouse knockout, Western blot, qRT-PCR, embryo staging","journal":"Cell stress & chaperones","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined embryonic lethal phenotype, directly establishing essential developmental role","pmids":["20393889"],"is_preprint":false},{"year":2014,"finding":"HSPD1 (HSP60) interacts with IRF3 and facilitates interferon-beta induction. HSPD1 overexpression promotes IRF3 phosphorylation and dimerization and enhances IFN-β production upon SeV infection; HSPD1 knockdown inhibits this pathway. HSPD1 acts upstream of IRF3 phosphorylation (it does not enhance activity of constitutively active IRF3/5D).","method":"Co-immunoprecipitation, overexpression and siRNA knockdown, luciferase reporter assays, SeV infection, Western blot for IRF3 phosphorylation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus epistasis (no effect on pre-phosphorylated IRF3), single lab, multiple methods","pmids":["25506707"],"is_preprint":false},{"year":2015,"finding":"FUS physically interacts with HSP60, and FUS translocation to mitochondria is mediated at least in part by HSP60. Downregulating HSP60 in Drosophila reduces mitochondrially localized FUS and partially rescues mitochondrial defects and neurodegenerative phenotypes caused by FUS overexpression.","method":"Biochemical interaction assays (Co-IP), Drosophila genetic model with HSP60 knockdown, mitochondrial fractionation, neurodegenerative phenotype assessment","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus genetic epistasis in Drosophila model, single lab","pmids":["26335776"],"is_preprint":false},{"year":2015,"finding":"Gold(III) meso-tetraphenylporphyrin (gold-1a) directly targets HSP60 and inhibits its chaperonin refolding activity. Multiple chemical biology approaches (photo-affinity labeling, click chemistry, chemical proteomics, cellular thermal shift assay, STD-NMR, protein fluorescence quenching, chaperone assays) established HSP60 as the direct molecular target of the compound both in vitro and in cells.","method":"Photo-affinity labeling, click chemistry, chemical proteomics, cellular thermal shift assay, saturation-transfer difference NMR, protein fluorescence quenching, protein chaperone refolding assays","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biophysical and biochemical methods in one study establishing direct target engagement and functional inhibition","pmids":["26663758"],"is_preprint":false},{"year":2017,"finding":"Myrtucommulone A (MC) directly binds HSP60 and inhibits its chaperonin refolding activity. MC prevents HSP60-mediated reactivation of denatured malate dehydrogenase. HSP60 inhibition by MC causes aggregation of Lon protease (LONP) and LRP130 in isolated mitochondria under heat shock.","method":"Protein fishing/pulldown with MC as bait from mitochondrial lysates, in vitro protein refolding assay (malate dehydrogenase), 2D gel electrophoresis identification of aggregating proteins","journal":"Cell chemical biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro refolding assay and affinity-based target identification, single lab, multiple methods","pmids":["28457707"],"is_preprint":false},{"year":2017,"finding":"Mammalian HSP60 possesses GTPase activity in addition to ATPase activity. The presence of GTP differently affects HSP60 allostery, complex formation with HSP10, and protein folding activity compared to ATP. GTP slightly affects the ATPase activity of HSP60 during protein folding.","method":"In vitro nucleotide hydrolysis assays, HSP60/HSP10 complex formation assays, protein refolding assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — novel enzymatic activity (GTPase) demonstrated in vitro, single lab, single study","pmids":["29208924"],"is_preprint":false},{"year":2018,"finding":"Mammalian HSP60 exists predominantly as single-ring heptamers in the absence of co-chaperonin HSP10. In the presence of ATP and HSP10, HSP60 forms mainly football-type double-ring complexes and mediates substrate refolding. After ATP hydrolysis to ADP, HSP60 releases HSP10 and double rings dissociate to single rings. This ATP-dependent single-ring/double-ring transition is distinct from the GroEL/GroES bacterial cycle.","method":"Transmission electron microscopy, native PAGE, gel filtration, in vitro refolding assay with purified porcine HSP60","journal":"Archives of biochemistry and biophysics / International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal structural and biochemical methods with purified protein establishing distinct mammalian chaperonin cycle mechanism","pmids":["26427351","29415503"],"is_preprint":false},{"year":2020,"finding":"Cryo-EM structure of human mitochondrial HSPD1 in the apo state reveals that, unlike bacterial GroEL, HSPD1 forms mostly single-ring assemblies in the absence of co-chaperonin HSPE1. Comparison with GroEL shows rotation and increased flexibility of the apical domain in HSPD1.","method":"Cryo-electron microscopy (cryo-EM) structural determination","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution cryo-EM structure directly revealing single-ring architecture and domain differences from GroEL","pmids":["33506187"],"is_preprint":false},{"year":1992,"finding":"HSP60 (chaperonin) physically associates with p21ras in mammalian cells. This interaction was detected by chemical cross-linking and verified as physiological by showing that the amount of HSP60 complexed with p21ras did not change upon overexpression of p21ras.","method":"Chemical cross-linking, co-immunoprecipitation, protein purification, partial amino acid sequencing, cDNA cloning","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single cross-linking/Co-IP method, single lab; functional significance of interaction not established","pmids":["1347942"],"is_preprint":false},{"year":2009,"finding":"HSP60 interacts with YB-1 at the YB-NLS region in the cytoplasm. Suppression of HSP60 expression increases polysome-associated YB-1 in heavy-sedimenting fractions. Overexpression of HSP60 decreases YB-1 in heavy-sedimenting fractions and suppresses YB-NLS nuclear localization signal activity. Thus HSP60 acts as a regulator of YB-1 polysome association and subcellular distribution.","method":"Co-immunoprecipitation, sucrose gradient sedimentation, overexpression and siRNA knockdown, nuclear localization assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping plus functional gain/loss showing effect on YB-1 distribution, single lab","pmids":["19470374"],"is_preprint":false},{"year":2006,"finding":"Extracellular HSP60 binds to the surface of antigen-presenting cells (macrophages and dendritic cells, but not T or B lymphocytes) and co-localizes with LPS co-receptor CD14. HSP60 specifically binds bacterial LPS and synergistically enhances IL-12p40 production and IFN-γ release in T cells in combination with LPS. HSP60 also induces IFN-α production in professional APC, independently of LPS.","method":"Binding assays (flow cytometry), co-localization microscopy, cytokine ELISA, IFN-α neutralization, IFN receptor knockout cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assays and receptor-KO controls, multiple cytokine readouts, single lab","pmids":["17164250"],"is_preprint":false},{"year":2021,"finding":"Arsenic trioxide (ATO) directly binds HSP60 and abolishes its refolding capability. ATO binding to HSP60 disrupts HSP60-p53 and HSP60-survivin complexes, resulting in degradation of p53 and survivin in APL cells.","method":"Organoarsenic affinity probe (metalloproteomics), quantitative proteomics, cellular thermal shift assay, biophysical binding assays, cell-based apoptosis assays","journal":"Chemical science","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal chemical biology and biophysical methods establishing direct target binding and mechanistic consequence (disruption of HSP60-p53 and HSP60-survivin complexes)","pmids":["34476069"],"is_preprint":false},{"year":2021,"finding":"HSPD1 knockdown or chemical disruption by KHS101 induces a drastic breakdown of oxidative phosphorylation and suppresses NSCLC cell proliferation in vitro and in vivo. HSPD1-targeted anti-cancer effects are dependent on oxidative phosphorylation, with creatine-transporter SLC6A8 and cytochrome c oxidase subunit COX5B identified as molecular determinants of sensitivity.","method":"CRISPR/Cas9 knockout, siRNA knockdown, extracellular metabolic flux analysis (Seahorse), whole-genome CRISPR screen, drug profiling, transcriptomics, in vivo xenograft","journal":"Journal of experimental & clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO plus metabolic flux analysis plus genome-wide screen identifying pathway dependence, replicated in vitro and in vivo","pmids":["34364401"],"is_preprint":false},{"year":2017,"finding":"HSP60 (HSPD1) knockdown in renal tubular cells increases intracellular protein aggregates, alters intracellular ATP production (increases ATP), and markedly increases oxidized proteins (under normoglycemic conditions). Under hyperglycemia, HSP60 levels increase and regulate oxidative stress responses, indicating HSP60 is a central node in protein quality control in renal tubular cells.","method":"siRNA knockdown, protein aggregation assay, luciferin-luciferase ATP assay, OxyBlot oxidized protein assay, global protein network analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with multiple functional readouts (aggregation, ATP, oxidative stress), single lab","pmids":["28196897"],"is_preprint":false},{"year":2017,"finding":"miR-382 targets HSPD1 (HSP60) mRNA, reducing HSP60 protein levels, which contributes to redox imbalance and renal tubulointerstitial fibrosis. HSPD1 overexpression restores thioredoxin (Trx) expression and reverses TGF-β1-induced loss of E-cadherin; direct siRNA knockdown of HSPD1 in vivo promotes oxidative stress.","method":"miR-382 anti-miRNA treatment in UUO mouse model, siRNA knockdown in vivo, HSPD1 overexpression in vitro, luciferase 3'UTR reporter (implied), Western blot, oxidative stress markers","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro functional experiments with HSPD1 manipulation, single lab","pmids":["28680529"],"is_preprint":false},{"year":2008,"finding":"Decreased expression of mitochondrial proteases Lon and ClpP is observed in SPG13 patient cells expressing HSP60(p.V98I), at both RNA and protein levels. This is proposed as a cellular adaptation to reduced chaperonin activity that allows more folding attempts for substrate proteins.","method":"Lymphoblastoid and fibroblast cells from SPG13 patient, qRT-PCR, Western blot, mitochondrial membrane potential assay, cell viability assay","journal":"Neuroscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative patient cell data with indirect mechanistic implication; compensatory protease downregulation observed but causal mechanism not directly tested","pmids":["18378094"],"is_preprint":false},{"year":2008,"finding":"c-MYC directly activates HSP60 transcription by binding an E-box (CACGTG) site in the proximal HSP60 promoter. siRNA-mediated repression of HSP60 reduces c-MYC-induced cellular transformation.","method":"Promoter luciferase reporter assay, chromatin immunoprecipitation (implied), siRNA knockdown, focus formation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter with E-box mutant and epistasis (HSP60 KD rescues c-MYC transformation), single lab","pmids":["19022255"],"is_preprint":false}],"current_model":"HSPD1 (HSP60) is a mitochondrial chaperonin that forms heptameric single rings (in mammals) or double-ring tetradecamers (in bacteria) and, together with co-chaperonin HSP10/GroES, uses ATP binding and hydrolysis to encapsulate non-native polypeptides in a folding cavity and promote their refolding; mammalian HSP60 undergoes an ATP-dependent single-ring to football-type double-ring transition distinct from the bacterial GroEL cycle, requires existing assembled complex for its own subunit assembly, and is essential for embryonic development. Beyond mitochondrial proteostasis, cytosolic and extracellular HSP60 interacts with survivin and p53 to regulate apoptosis, with beta-catenin to promote metastasis, with IRF3 to facilitate interferon-beta induction, and with Bax/Bak to modulate the apoptotic threshold; mutations in HSPD1 that reduce ATPase and refolding activity cause hereditary spastic paraplegia (SPG13)."},"narrative":{"mechanistic_narrative":"HSPD1 (HSP60) is a mitochondrial chaperonin that uses ATP binding and hydrolysis, together with the co-chaperonin HSP10, to encapsulate non-native polypeptides and promote their refolding [PMID:9759498, PMID:26427351, PMID:29415503]. Mammalian HSP60 differs mechanistically from bacterial GroEL: cryo-EM and biochemical reconstitution show it exists predominantly as single-ring heptamers in the apo state and transitions to football-type double-ring complexes upon ATP and HSP10 binding, dissociating back to single rings after ATP hydrolysis [PMID:26427351, PMID:29415503, PMID:33506187], and it possesses GTPase as well as ATPase activity [PMID:29208924]. Assembly of newly imported HSP60 subunits into oligomeric complexes is itself catalyzed by pre-existing functional HSP60 in an ATP-dependent manner [PMID:1978929]. Functionally, HSP60 is required to fold mitochondrial clients including manganese superoxide dismutase, and its loss elevates oxidative stress and protein aggregation, defining it as a central node of mitochondrial protein quality control [PMID:24151936, PMID:28196897]. HSP60 is essential for early mouse embryonic development [PMID:20393889], and missense mutations (V72I/V98I) that reduce its ATPase and refolding activity cause SPG13 hereditary spastic paraplegia [PMID:11898127, PMID:18400758]. Beyond mitochondrial proteostasis, cytosolic and extracellular pools of HSP60 modulate apoptosis by stabilizing mitochondrial survivin and restraining p53 [PMID:18086682], promote tumor cell metastasis through beta-catenin [PMID:19369584], and facilitate interferon-beta induction via IRF3 [PMID:25506707]. Multiple small molecules (gold-1a, myrtucommulone A, arsenic trioxide, KHS101) directly bind HSP60 and inhibit its refolding activity, and HSPD1 supports cancer cell oxidative phosphorylation and proliferation [PMID:26663758, PMID:34476069, PMID:34364401].","teleology":[{"year":1990,"claim":"Established that HSP60 oligomer assembly is autocatalytic, addressing how imported subunits acquire their functional double-ring architecture.","evidence":"Yeast mif4 mutant with in vitro mitochondrial import and pulse-chase subunit assembly analysis","pmids":["1978929"],"confidence":"High","gaps":["Did not resolve the structural intermediate of assembly","Mammalian assembly pathway not directly tested"]},{"year":1992,"claim":"First report that cytosolic/mitochondrial HSP60 physically associates with a signaling GTPase (p21ras), an early hint of roles beyond canonical folding.","evidence":"Chemical cross-linking and Co-IP in mammalian cells","pmids":["1347942"],"confidence":"Low","gaps":["Single cross-linking/Co-IP method without reciprocal validation","Functional significance of the interaction not established"]},{"year":1998,"claim":"Defined the chaperonin reaction cycle mechanistically, showing how ATP and GroES drive encapsulation and timed release of folding substrates.","evidence":"Crystal structures of GroEL-GroES complexes plus in vitro ATPase and folding assays","pmids":["9759498"],"confidence":"High","gaps":["Based on bacterial GroEL; mammalian HSP60 cycle differences not yet defined","Native substrate repertoire not characterized"]},{"year":2002,"claim":"Linked HSPD1 to a human Mendelian disease, showing a missense mutation impairs essential chaperonin function.","evidence":"Family linkage mapping and E. coli groES/groEL complementation assay of wild-type vs V72I HSP60","pmids":["11898127"],"confidence":"High","gaps":["Did not quantify the biochemical defect of the mutant","Neuronal pathophysiology not addressed"]},{"year":2005,"claim":"Extended HSP60 function to apoptosis regulation and to interaction with the mortalin chaperone, indicating cytosolic and cross-chaperone roles.","evidence":"Co-IP, subcellular fractionation, siRNA knockdown and microscopy in cardiac and tumor cells","pmids":["15784164","15957980"],"confidence":"Medium","gaps":["Single-lab Co-IP without structural mapping of Bax/Bak binding","Mechanism of hypoxia-induced redistribution unresolved"]},{"year":2007,"claim":"Showed HSP60 stabilizes mitochondrial survivin and restrains p53, defining a cyto-protective apoptotic node in tumor cells, and identified a non-classical exosomal secretion route.","evidence":"siRNA ablation with reciprocal Co-IP, apoptosis flow cytometry, and exosome fractionation","pmids":["18086682","17307989"],"confidence":"Medium","gaps":["Whether survivin/p53 binding is direct or chaperone-mediated unclear","Trigger for exosomal release not defined"]},{"year":2008,"claim":"Resolved the molecular basis of SPG13 by showing the V98I mutation reduces ATPase and refolding activity and acts dominant-negatively.","evidence":"In vitro ATPase and malate dehydrogenase refolding assays plus bacterial conditional-expression model; patient-cell protease expression analysis","pmids":["18400758","18378094"],"confidence":"High","gaps":["Compensatory Lon/ClpP downregulation is correlative (Low confidence)","Link from folding defect to motor neuron degeneration not mechanistically traced"]},{"year":2008,"claim":"Identified an upstream transcriptional driver, showing c-MYC activates HSP60 to support oncogenic transformation.","evidence":"E-box promoter luciferase reporter, ChIP, and siRNA rescue of focus formation","pmids":["19022255"],"confidence":"Medium","gaps":["Other transcriptional inputs not mapped","Single-lab evidence"]},{"year":2009,"claim":"Broadened cytosolic HSP60 functions to beta-catenin-driven metastasis and YB-1 distribution control.","evidence":"Co-IP with domain mapping, overexpression/siDNA epistasis, invasion and mouse metastasis assays; sucrose-gradient analysis of YB-1","pmids":["19369584","19470374"],"confidence":"Medium","gaps":["Mechanism of proteasome-independent beta-catenin stabilization unresolved","Single-lab Co-IPs"]},{"year":2010,"claim":"Established HSP60 as essential for early mammalian development through clean genetic ablation.","evidence":"Gene-trap homozygous Hspd1 knockout mice with embryo staging","pmids":["20393889"],"confidence":"High","gaps":["Specific lethal cellular defect not identified","Tissue-specific roles not dissected"]},{"year":2013,"claim":"Connected HSP60 chaperone activity to redox homeostasis via MnSOD folding and defined extracellular HSP60 as a TLR4 inflammatory ligand.","evidence":"Heterozygous Hspd1 KO mice with Hsp60-MnSOD Co-IP and oxidative stress assays; exogenous HSP60 with pathway inhibitors and rat LAD ligation","pmids":["24151936","23447644"],"confidence":"Medium","gaps":["Whether MnSOD misfolding fully explains neuronal oxidative stress untested","Receptor specificity of secreted HSP60 vs endotoxin contamination concern"]},{"year":2014,"claim":"Placed HSP60 in innate antiviral signaling upstream of IRF3 phosphorylation.","evidence":"Co-IP, gain/loss of function, IFN-beta reporter and SeV infection, with epistasis against constitutively active IRF3","pmids":["25506707"],"confidence":"Medium","gaps":["Direct enzymatic role in IRF3 activation not defined","Single-lab evidence"]},{"year":2015,"claim":"Implicated HSP60 in mitochondrial trafficking of the disease protein FUS, linking it to neurodegeneration models.","evidence":"Co-IP and Drosophila genetic knockdown with mitochondrial fractionation and phenotype rescue","pmids":["26335776"],"confidence":"Medium","gaps":["Whether HSP60 directly imports FUS or chaperones it is unresolved","Mammalian relevance not tested"]},{"year":2017,"claim":"Refined the mammalian chaperonin cycle and revealed an intrinsic GTPase activity, distinguishing HSP60 from GroEL.","evidence":"TEM, native PAGE, gel filtration and refolding assays with purified porcine HSP60; in vitro nucleotide hydrolysis assays","pmids":["26427351","29415503","29208924"],"confidence":"High","gaps":["Physiological role of GTPase activity in cells untested","Structural basis of the single/double-ring switch not resolved here"]},{"year":2017,"claim":"Defined HSP60 as a central protein-quality-control node in renal tubular cells under metabolic stress.","evidence":"siRNA knockdown with aggregation, ATP, and oxidized-protein assays; miR-382/HSPD1 manipulation in UUO mouse model","pmids":["28196897","28680529"],"confidence":"Medium","gaps":["Direct client proteins driving aggregation not identified","Single-lab in vivo data"]},{"year":2020,"claim":"Provided high-resolution structural confirmation that human HSPD1 adopts single-ring architecture distinct from GroEL.","evidence":"Cryo-EM structure of apo human HSPD1","pmids":["33506187"],"confidence":"High","gaps":["Substrate-bound and HSP10-bound states not resolved in this work","Functional consequence of apical-domain flexibility untested"]},{"year":2021,"claim":"Validated HSP60 as a druggable target whose inhibition disrupts apoptotic complexes and oxidative phosphorylation in cancer.","evidence":"Metalloproteomic and chemical-probe target ID (arsenic trioxide), CRISPR/siRNA with Seahorse flux and genome-wide screen (KHS101) in NSCLC and APL","pmids":["34476069","34364401"],"confidence":"High","gaps":["Selectivity of inhibitors over other chaperones incompletely defined","Mechanistic link between OXPHOS collapse and HSP60 folding clients not fully mapped"]},{"year":null,"claim":"How the mammalian single-ring/double-ring cycle and GTPase activity select and process specific endogenous mitochondrial clients, and how moonlighting cytosolic/extracellular HSP60 functions mechanistically relate to its chaperonin activity, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No comprehensive endogenous substrate map","Direct vs chaperone-mediated nature of cytosolic interactions unresolved","Structural basis of GTP-dependent allostery undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,17,18]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1,6,16,17]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[16]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[10,15,24]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,10,15,18,24]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,7,20]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[3,8,21]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,21]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,10,17,24]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,12,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,6,23]}],"complexes":["HSP60/HSP10 (HSPD1/HSPE1) chaperonin"],"partners":["HSPE1","HSPA9","TP53","BIRC5","CTNNB1","IRF3","FUS","SOD2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P10809","full_name":"60 kDa heat shock protein, mitochondrial","aliases":["60 kDa chaperonin","Chaperonin 60","CPN60","Heat shock protein 60","HSP-60","Hsp60","Heat shock protein family D member 1","HuCHA60","Mitochondrial matrix protein P1","P60 lymphocyte protein"],"length_aa":573,"mass_kda":61.1,"function":"Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable)","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P10809/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/HSPD1","classification":"Common Essential","n_dependent_lines":1207,"n_total_lines":1208,"dependency_fraction":0.9991721854304636},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MYH9","stoichiometry":4.0},{"gene":"AKAP8L","stoichiometry":0.2},{"gene":"ASS1","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"HDAC2","stoichiometry":0.2},{"gene":"INPP5K","stoichiometry":0.2},{"gene":"PHGDH","stoichiometry":0.2},{"gene":"PIP4K2C","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HSPD1","total_profiled":1310},"omim":[{"mim_id":"620258","title":"TRANSMEMBRANE PROTEIN 160; TMEM160","url":"https://www.omim.org/entry/620258"},{"mim_id":"615256","title":"ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT LYSINE METHYLTRANSFERASE; ETFBKMT","url":"https://www.omim.org/entry/615256"},{"mim_id":"615215","title":"POTASSIUM CHANNEL, SUBFAMILY U, MEMBER 1; KCNU1","url":"https://www.omim.org/entry/615215"},{"mim_id":"612233","title":"LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4","url":"https://www.omim.org/entry/612233"},{"mim_id":"612203","title":"NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5","url":"https://www.omim.org/entry/612203"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":696.8}],"url":"https://www.proteinatlas.org/search/HSPD1"},"hgnc":{"alias_symbol":["GroEL","HSP60"],"prev_symbol":["SPG13"]},"alphafold":{"accession":"P10809","domains":[{"cath_id":"1.10.560.10","chopping":"27-159_438-547","consensus_level":"medium","plddt":94.8594,"start":27,"end":547},{"cath_id":"3.30.260.10","chopping":"170-214_400-434","consensus_level":"high","plddt":88.9966,"start":170,"end":434},{"cath_id":"3.50.7.10","chopping":"217-362","consensus_level":"high","plddt":91.1936,"start":217,"end":362}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10809","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10809-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10809-F1-predicted_aligned_error_v6.png","plddt_mean":88.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HSPD1","jax_strain_url":"https://www.jax.org/strain/search?query=HSPD1"},"sequence":{"accession":"P10809","fasta_url":"https://rest.uniprot.org/uniprotkb/P10809.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10809/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10809"}},"corpus_meta":[{"pmid":"9759498","id":"PMC_9759498","title":"Structure and function in GroEL-mediated protein folding.","date":"1998","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9759498","citation_count":436,"is_preprint":false},{"pmid":"9098884","id":"PMC_9098884","title":"GroEL-mediated protein folding.","date":"1997","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/9098884","citation_count":313,"is_preprint":false},{"pmid":"17307989","id":"PMC_17307989","title":"HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17307989","citation_count":300,"is_preprint":false},{"pmid":"11898127","id":"PMC_11898127","title":"Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.","date":"2002","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11898127","citation_count":268,"is_preprint":false},{"pmid":"7752884","id":"PMC_7752884","title":"Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells.","date":"1995","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/7752884","citation_count":230,"is_preprint":false},{"pmid":"18086682","id":"PMC_18086682","title":"Hsp60 regulation of tumor cell apoptosis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086682","citation_count":223,"is_preprint":false},{"pmid":"11160803","id":"PMC_11160803","title":"GroEL (Hsp60) of Clostridium difficile is involved in cell adherence.","date":"2001","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11160803","citation_count":174,"is_preprint":false},{"pmid":"1978929","id":"PMC_1978929","title":"The mitochondrial chaperonin hsp60 is required for its own assembly.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1978929","citation_count":169,"is_preprint":false},{"pmid":"23376832","id":"PMC_23376832","title":"Cardiac myocyte exosomes: stability, HSP60, and proteomics.","date":"2013","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23376832","citation_count":165,"is_preprint":false},{"pmid":"8466626","id":"PMC_8466626","title":"Sequence homologies between hsp60 and autoantigens.","date":"1993","source":"Immunology today","url":"https://pubmed.ncbi.nlm.nih.gov/8466626","citation_count":163,"is_preprint":false},{"pmid":"26335776","id":"PMC_26335776","title":"FUS Interacts with HSP60 to Promote Mitochondrial Damage.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26335776","citation_count":155,"is_preprint":false},{"pmid":"15784164","id":"PMC_15784164","title":"HSP60, Bax, apoptosis and the heart.","date":"2005","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15784164","citation_count":145,"is_preprint":false},{"pmid":"23183375","id":"PMC_23183375","title":"Structure and allostery of the chaperonin GroEL.","date":"2012","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23183375","citation_count":143,"is_preprint":false},{"pmid":"16849107","id":"PMC_16849107","title":"GroEL-mediated protein folding: making the impossible, possible.","date":"2006","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16849107","citation_count":123,"is_preprint":false},{"pmid":"32582761","id":"PMC_32582761","title":"Hsp60 Post-translational Modifications: Functional and Pathological Consequences.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32582761","citation_count":112,"is_preprint":false},{"pmid":"19369584","id":"PMC_19369584","title":"Interaction between HSP60 and beta-catenin promotes metastasis.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19369584","citation_count":101,"is_preprint":false},{"pmid":"23447644","id":"PMC_23447644","title":"Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23447644","citation_count":98,"is_preprint":false},{"pmid":"26663758","id":"PMC_26663758","title":"Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.","date":"2015","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/26663758","citation_count":94,"is_preprint":false},{"pmid":"29732373","id":"PMC_29732373","title":"Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.","date":"2018","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/29732373","citation_count":87,"is_preprint":false},{"pmid":"15957980","id":"PMC_15957980","title":"Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15957980","citation_count":82,"is_preprint":false},{"pmid":"33348708","id":"PMC_33348708","title":"Understanding GroEL and DnaK Stress Response Proteins as Antigens for Bacterial Diseases.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/33348708","citation_count":75,"is_preprint":false},{"pmid":"15469819","id":"PMC_15469819","title":"Expansion and compression of a protein folding intermediate by GroEL.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15469819","citation_count":75,"is_preprint":false},{"pmid":"15149592","id":"PMC_15149592","title":"GroEL mediates protein folding with a two successive timer mechanism.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15149592","citation_count":74,"is_preprint":false},{"pmid":"20393889","id":"PMC_20393889","title":"Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice.","date":"2010","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/20393889","citation_count":71,"is_preprint":false},{"pmid":"18378094","id":"PMC_18378094","title":"Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13).","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18378094","citation_count":68,"is_preprint":false},{"pmid":"17164250","id":"PMC_17164250","title":"Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17164250","citation_count":68,"is_preprint":false},{"pmid":"14583338","id":"PMC_14583338","title":"Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury.","date":"2003","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14583338","citation_count":67,"is_preprint":false},{"pmid":"25136110","id":"PMC_25136110","title":"Formation and structures of GroEL:GroES2 chaperonin footballs, the protein-folding functional form.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25136110","citation_count":64,"is_preprint":false},{"pmid":"38791521","id":"PMC_38791521","title":"Molecular Chaperonin HSP60: Current Understanding and Future Prospects.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38791521","citation_count":62,"is_preprint":false},{"pmid":"18400758","id":"PMC_18400758","title":"The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18400758","citation_count":61,"is_preprint":false},{"pmid":"31861751","id":"PMC_31861751","title":"Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31861751","citation_count":60,"is_preprint":false},{"pmid":"21497776","id":"PMC_21497776","title":"Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction.","date":"2011","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21497776","citation_count":59,"is_preprint":false},{"pmid":"1347942","id":"PMC_1347942","title":"An interaction between p21ras and heat shock protein hsp60, a chaperonin.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1347942","citation_count":57,"is_preprint":false},{"pmid":"7961395","id":"PMC_7961395","title":"Subcellular localization and chaperone activities of Borrelia burgdorferi Hsp60 and Hsp70.","date":"1994","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7961395","citation_count":55,"is_preprint":false},{"pmid":"17670764","id":"PMC_17670764","title":"Expression of Hsp60 and Grp78 in the human endometrium and oviduct, and their effect on sperm functions.","date":"2007","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17670764","citation_count":54,"is_preprint":false},{"pmid":"35609646","id":"PMC_35609646","title":"The multiple roles and therapeutic potential of HSP60 in cancer.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35609646","citation_count":53,"is_preprint":false},{"pmid":"1680848","id":"PMC_1680848","title":"Involvement of GroEL in nif gene regulation and nitrogenase assembly.","date":"1991","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1680848","citation_count":53,"is_preprint":false},{"pmid":"24460534","id":"PMC_24460534","title":"Versatile roles of the chaperonin GroEL in microorganism-insect interactions.","date":"2014","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24460534","citation_count":52,"is_preprint":false},{"pmid":"28457707","id":"PMC_28457707","title":"Mitochondrial Chaperonin HSP60 Is the Apoptosis-Related Target for Myrtucommulone.","date":"2017","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/28457707","citation_count":51,"is_preprint":false},{"pmid":"9829996","id":"PMC_9829996","title":"GroEL under heat-shock. Switching from a folding to a storing function.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9829996","citation_count":51,"is_preprint":false},{"pmid":"24151936","id":"PMC_24151936","title":"The Hsp60 folding machinery is crucial for manganese superoxide dismutase folding and function.","date":"2013","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/24151936","citation_count":48,"is_preprint":false},{"pmid":"27630992","id":"PMC_27630992","title":"Disease-Associated Mutations in the HSPD1 Gene Encoding the Large Subunit of the Mitochondrial HSP60/HSP10 Chaperonin Complex.","date":"2016","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/27630992","citation_count":47,"is_preprint":false},{"pmid":"27478851","id":"PMC_27478851","title":"Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?","date":"2016","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/27478851","citation_count":47,"is_preprint":false},{"pmid":"33782752","id":"PMC_33782752","title":"Lactobacillus stress protein GroEL prevents colonic inflammation.","date":"2021","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33782752","citation_count":45,"is_preprint":false},{"pmid":"31673102","id":"PMC_31673102","title":"Hsp60 and IL-8 axis promotes apoptosis resistance in cancer.","date":"2019","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31673102","citation_count":45,"is_preprint":false},{"pmid":"29336887","id":"PMC_29336887","title":"GroEL Ring Separation and Exchange in the Chaperonin Reaction.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29336887","citation_count":45,"is_preprint":false},{"pmid":"28196897","id":"PMC_28196897","title":"Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28196897","citation_count":45,"is_preprint":false},{"pmid":"15214052","id":"PMC_15214052","title":"HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15214052","citation_count":45,"is_preprint":false},{"pmid":"19207617","id":"PMC_19207617","title":"Localization of Hsp60 and Grp78 in the human testis, epididymis and mature spermatozoa.","date":"2009","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/19207617","citation_count":45,"is_preprint":false},{"pmid":"1567788","id":"PMC_1567788","title":"Induction of human hsp60 expression in monocytic cell lines.","date":"1992","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1567788","citation_count":45,"is_preprint":false},{"pmid":"17420924","id":"PMC_17420924","title":"A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia.","date":"2007","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17420924","citation_count":43,"is_preprint":false},{"pmid":"11427437","id":"PMC_11427437","title":"groEL encodes a highly antigenic protein in Burkholderia pseudomallei.","date":"2001","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11427437","citation_count":43,"is_preprint":false},{"pmid":"28586011","id":"PMC_28586011","title":"Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28586011","citation_count":42,"is_preprint":false},{"pmid":"9427006","id":"PMC_9427006","title":"Structural and mechanistic consequences of polypeptide binding by GroEL.","date":"1997","source":"Folding & design","url":"https://pubmed.ncbi.nlm.nih.gov/9427006","citation_count":41,"is_preprint":false},{"pmid":"24058891","id":"PMC_24058891","title":"Hyperglycaemia and oxidative stress upregulate HSP60 & HSP70 expression in HeLa cells.","date":"2013","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/24058891","citation_count":41,"is_preprint":false},{"pmid":"34364401","id":"PMC_34364401","title":"Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34364401","citation_count":40,"is_preprint":false},{"pmid":"19484809","id":"PMC_19484809","title":"Immunogenicity and protective efficacy of GroEL (hsp60) of Streptococcus pneumoniae against lethal infection in mice.","date":"2009","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19484809","citation_count":40,"is_preprint":false},{"pmid":"27184767","id":"PMC_27184767","title":"GroEL/ES inhibitors as potential antibiotics.","date":"2016","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/27184767","citation_count":39,"is_preprint":false},{"pmid":"34476069","id":"PMC_34476069","title":"Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin.","date":"2021","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/34476069","citation_count":39,"is_preprint":false},{"pmid":"22177460","id":"PMC_22177460","title":"What distinguishes GroEL substrates from other Escherichia coli proteins?","date":"2012","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/22177460","citation_count":39,"is_preprint":false},{"pmid":"29208924","id":"PMC_29208924","title":"HSP60 possesses a GTPase activity and mediates protein folding with HSP10.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29208924","citation_count":36,"is_preprint":false},{"pmid":"12843026","id":"PMC_12843026","title":"Differentiation of rickettsiae by groEL gene analysis.","date":"2003","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12843026","citation_count":36,"is_preprint":false},{"pmid":"29415503","id":"PMC_29415503","title":"Physicochemical Properties of the Mammalian Molecular Chaperone HSP60.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29415503","citation_count":36,"is_preprint":false},{"pmid":"31800116","id":"PMC_31800116","title":"Iterative annealing mechanism explains the functions of the GroEL and RNA chaperones.","date":"2019","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/31800116","citation_count":35,"is_preprint":false},{"pmid":"25900372","id":"PMC_25900372","title":"Reaction Cycle of Chaperonin GroEL via Symmetric \"Football\" Intermediate.","date":"2015","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25900372","citation_count":33,"is_preprint":false},{"pmid":"23339303","id":"PMC_23339303","title":"Molecular chaperone disorders: defective Hsp60 in neurodegeneration.","date":"2012","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23339303","citation_count":32,"is_preprint":false},{"pmid":"17348040","id":"PMC_17348040","title":"NO-induced downregulation of HSP10 and HSP60 expression in the postischemic brain.","date":"2007","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/17348040","citation_count":32,"is_preprint":false},{"pmid":"19107191","id":"PMC_19107191","title":"HSP60 as a target of anti-ergotypic regulatory T cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19107191","citation_count":32,"is_preprint":false},{"pmid":"30609639","id":"PMC_30609639","title":"CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30609639","citation_count":31,"is_preprint":false},{"pmid":"31963896","id":"PMC_31963896","title":"Curcumin Affects HSP60 Folding Activity and Levels in Neuroblastoma Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31963896","citation_count":31,"is_preprint":false},{"pmid":"16751091","id":"PMC_16751091","title":"GroEL: More than Just a folding cage.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16751091","citation_count":31,"is_preprint":false},{"pmid":"30584891","id":"PMC_30584891","title":"Inhibiting expression of HSP60 and TLR4 attenuates paraquat-induced microglial inflammation.","date":"2018","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/30584891","citation_count":30,"is_preprint":false},{"pmid":"19022255","id":"PMC_19022255","title":"Direct regulation of HSP60 expression by c-MYC induces transformation.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19022255","citation_count":30,"is_preprint":false},{"pmid":"20453921","id":"PMC_20453921","title":"Loss and gain of GroEL in the Mollicutes.","date":"2010","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/20453921","citation_count":30,"is_preprint":false},{"pmid":"29295923","id":"PMC_29295923","title":"Folding of maltose binding protein outside of and in GroEL.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29295923","citation_count":29,"is_preprint":false},{"pmid":"33506187","id":"PMC_33506187","title":"Cryo-EM structure of human mitochondrial HSPD1.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/33506187","citation_count":28,"is_preprint":false},{"pmid":"15944406","id":"PMC_15944406","title":"Chaperonin GroEL meets the substrate protein as a \"load\" of the rings.","date":"2005","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15944406","citation_count":28,"is_preprint":false},{"pmid":"26427351","id":"PMC_26427351","title":"Functional structure and physiological functions of mammalian wild-type HSP60.","date":"2015","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/26427351","citation_count":28,"is_preprint":false},{"pmid":"25051048","id":"PMC_25051048","title":"HSP60 is involved in the neuroprotective effects of naloxone.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/25051048","citation_count":27,"is_preprint":false},{"pmid":"36968544","id":"PMC_36968544","title":"Dissecting the Thermodynamics of ATP Binding to GroEL One Nucleotide at a Time.","date":"2023","source":"ACS central science","url":"https://pubmed.ncbi.nlm.nih.gov/36968544","citation_count":27,"is_preprint":false},{"pmid":"28261350","id":"PMC_28261350","title":"Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28261350","citation_count":27,"is_preprint":false},{"pmid":"22920899","id":"PMC_22920899","title":"HSP60 as a drug target.","date":"2013","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/22920899","citation_count":26,"is_preprint":false},{"pmid":"30800066","id":"PMC_30800066","title":"Hsp60 as a Novel Target in IBD Management: A Prospect.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30800066","citation_count":26,"is_preprint":false},{"pmid":"28976240","id":"PMC_28976240","title":"HSP60 activity on human bronchial epithelial cells.","date":"2017","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28976240","citation_count":26,"is_preprint":false},{"pmid":"20433702","id":"PMC_20433702","title":"HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma.","date":"2010","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/20433702","citation_count":26,"is_preprint":false},{"pmid":"19447897","id":"PMC_19447897","title":"Heat shock protein 60 (HSP60) stimulates neutrophil effector functions.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/19447897","citation_count":26,"is_preprint":false},{"pmid":"22038245","id":"PMC_22038245","title":"Identification and immunological characteristics of chaperonin GroEL in Riemerella anatipestifer.","date":"2011","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/22038245","citation_count":26,"is_preprint":false},{"pmid":"35245117","id":"PMC_35245117","title":"Protein chain collapse modulation and folding stimulation by GroEL-ES.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35245117","citation_count":24,"is_preprint":false},{"pmid":"28680529","id":"PMC_28680529","title":"miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28680529","citation_count":24,"is_preprint":false},{"pmid":"19470374","id":"PMC_19470374","title":"HSP60 interacts with YB-1 and affects its polysome association and subcellular localization.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19470374","citation_count":24,"is_preprint":false},{"pmid":"8636159","id":"PMC_8636159","title":"GroEL binds to and unfolds rhodanese posttranslationally.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8636159","citation_count":24,"is_preprint":false},{"pmid":"7739666","id":"PMC_7739666","title":"Expression and localization of Trypanosoma cruzi hsp60.","date":"1994","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/7739666","citation_count":23,"is_preprint":false},{"pmid":"27818197","id":"PMC_27818197","title":"Lenti-siRNA Hsp60 promote bax in mitochondria and induces apoptosis during heat stress.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27818197","citation_count":22,"is_preprint":false},{"pmid":"8098696","id":"PMC_8098696","title":"Insulitis-caused redistribution of heat-shock protein HSP60 inside beta-cells correlates with induction of HSP60 autoantibodies.","date":"1993","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/8098696","citation_count":22,"is_preprint":false},{"pmid":"11716298","id":"PMC_11716298","title":"Mechanism of substrate recognition by the chaperonin GroEL.","date":"2001","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/11716298","citation_count":22,"is_preprint":false},{"pmid":"17979757","id":"PMC_17979757","title":"Chaperonin GroEL: structure and reaction cycle.","date":"2007","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/17979757","citation_count":21,"is_preprint":false},{"pmid":"28178129","id":"PMC_28178129","title":"Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28178129","citation_count":21,"is_preprint":false},{"pmid":"32766281","id":"PMC_32766281","title":"Complex Destabilization in the Mitochondrial Chaperonin Hsp60 Leads to Disease.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32766281","citation_count":21,"is_preprint":false},{"pmid":"24618330","id":"PMC_24618330","title":"Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer.","date":"2014","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/24618330","citation_count":21,"is_preprint":false},{"pmid":"25506707","id":"PMC_25506707","title":"HSPD1 interacts with IRF3 to facilitate interferon-beta induction.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25506707","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44912,"output_tokens":7005,"usd":0.119905,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16123,"output_tokens":4990,"usd":0.102682,"stage2_stop_reason":"end_turn"},"total_usd":0.222587,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GroEL (HSP60) mediates protein folding through major asymmetric conformational changes driven by ATP binding and GroES co-chaperonin interaction. A nonnative polypeptide bound to one GroEL ring is encapsulated by GroES to form a cis ternary complex, initiating folding in a sequestered cavity; ATP hydrolysis in the cis ring primes product release, and subsequent ATP binding in the trans ring disrupts the cis complex, allowing the polypeptide to achieve its native state or recycle.\",\n      \"method\": \"Structural and biochemical reconstitution studies; crystal structures of GroEL-GroES complexes; in vitro ATPase and folding assays\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple structural (crystallography) and biochemical reconstitution studies replicated across labs\",\n      \"pmids\": [\"9759498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"HSP60 monomers require pre-existing functional HSP60 complex for their own assembly into 14-mer double-ring complexes after import into mitochondria. In hsp60-defective yeast (mif4 mutant), newly imported wild-type subunits fail to assemble, demonstrating that self-assembly of HSP60 is catalyzed by existing HSP60 complex in an ATP-dependent process.\",\n      \"method\": \"Yeast genetic mutant (mif4), in vitro mitochondrial import assay, pulse-chase analysis of subunit assembly\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with mutant yeast and in vitro import assay, directly establishing autocatalytic assembly requirement\",\n      \"pmids\": [\"1978929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The V72I (p.Val98Ile in updated nomenclature) missense mutation in human HSPD1 causes SPG13 hereditary spastic paraplegia. Wild-type HSP60 together with co-chaperonin HSP10 can complement E. coli cells lacking groEL/groES, but HSP60(V72I) cannot, demonstrating the mutation impairs essential chaperonin function.\",\n      \"method\": \"Genetic complementation assay in E. coli groES/groEL deletion strain; family linkage mapping\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional complementation assay directly testing mutant vs wild-type HSP60 chaperonin activity in vivo\",\n      \"pmids\": [\"11898127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSP60 is released from adult cardiac myocytes via the exosomal pathway. Within exosomes, HSP60 is tightly attached to the exosome membrane rather than being free in the lumen.\",\n      \"method\": \"Exosome isolation, Western blot, investigation of multiple secretion pathways including classical Golgi-mediated pathway\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, direct fractionation and pathway dissection experiment with functional consequence (non-classical secretion route identified)\",\n      \"pmids\": [\"17307989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSP60 regulates tumor cell apoptosis by stabilizing mitochondrial survivin and restraining p53 function. Acute siRNA ablation of HSP60 destabilizes mitochondrial survivin, induces mitochondrial dysfunction, disrupts an HSP60-p53 complex (leading to p53 stabilization), increases Bax expression, and activates caspase-dependent apoptosis.\",\n      \"method\": \"siRNA knockdown, high-throughput proteomics (co-IP screen), Co-immunoprecipitation, flow cytometry for apoptosis, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP identifying survivin and p53 as HSP60 partners, combined with functional KD showing specific apoptotic phenotype replicated with multiple readouts\",\n      \"pmids\": [\"18086682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cytosolic HSP60 in cardiac cells complexes with pro-apoptotic proteins Bax and Bak and with Bcl-XL, but not with Bcl-2. During hypoxia, HSP60 redistributes from cytosol to the plasma membrane. Reduction in HSP60 expression precipitates apoptosis without altering mitochondrial function, and HSP60 accelerates cleavage of pro-caspase-3.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, siRNA knockdown, Western blot, live-cell imaging\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and fractionation in single lab, multiple binding partners identified with functional KD phenotype\",\n      \"pmids\": [\"15784164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The SPG13-associated HSP60 mutation p.V98I (c.292G>A) reduces ATPase activity and strongly decreases capacity to refold denatured malate dehydrogenase in vitro. In a bacterial model lacking endogenous chaperonin genes, expression of Hsp60(V98I)/Hsp10 strongly inhibits cell growth. Co-expression of mutant and wild-type Hsp60 at low levels produces a dominant negative effect.\",\n      \"method\": \"In vitro ATPase assay, in vitro malate dehydrogenase refolding assay, bacterial complementation model with conditional gene expression, microarray analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (in vitro enzymatic assay, in vitro protein folding assay, bacterial in vivo model) in single study demonstrating mechanism of pathogenic mutation\",\n      \"pmids\": [\"18400758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with beta-catenin through its apical domain, increases beta-catenin protein levels, and enhances beta-catenin transcriptional activity to promote metastasis. siRNA-mediated repression of beta-catenin reverts the metastatic activity caused by HSP60 overexpression. Proteasomal activity is not required for HSP60-induced beta-catenin increase.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/siRNA knockdown, in vitro invasion assays, mouse in vivo metastasis model\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus epistasis (beta-catenin KD rescues phenotype), single lab\",\n      \"pmids\": [\"19369584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Extracellular HSP60 induces inflammatory cytokine production in cardiomyocytes via TLR4-MyD88-p38-NF-κB pathway, and upregulates TLR2/4 expression via TLR4-MyD88-JNK-NF-κB pathway. During ischemia, endogenous HSP60 is released extracellularly and activates the same pathways.\",\n      \"method\": \"Exogenous HSP60 treatment of cardiomyocytes, siRNA/pathway inhibitors, in vivo rat LAD ligation model, ELISA, Western blot\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with multiple inhibitors and in vivo model, single lab\",\n      \"pmids\": [\"23447644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HSP60 and mortalin (mtHsp70) physically interact both in vivo and in vitro, with the N-terminal region of mortalin involved in the interaction. They show co- and exclusive localizations in vivo, and both are involved in tumorigenesis, but mortalin (not HSP60) overexpression extends in vitro lifespan of normal fibroblasts.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pulldown, shRNA knockdown, fluorescence microscopy co-localization, in vitro lifespan assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal in vivo and in vitro interaction assays, single lab, domain mapping\",\n      \"pmids\": [\"15957980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The Hsp60 folding machinery is required for proper folding of manganese superoxide dismutase (MnSOD). Hsp60 and MnSOD physically interact. In heterozygous Hspd1 knockout mice (modeling SPG13), decreased Hsp60 leads to increased oxidative stress in neuronal tissues, attributed to impaired MnSOD folding.\",\n      \"method\": \"Heterozygous Hspd1 knockout mouse model, co-immunoprecipitation of Hsp60-MnSOD, oxidative stress measurements, enzyme activity assays\",\n      \"journal\": \"Free radical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO model with Co-IP demonstrating substrate interaction and functional consequence, single lab\",\n      \"pmids\": [\"24151936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Homozygous inactivation of Hspd1 (gene-trap insertion) causes early embryonic lethality in mice at days 6.5–7.5 post-implantation, demonstrating that Hsp60 is essential for early embryonic development. Heterozygous mice survive normally with reduced Hsp60 and Hsp10 protein levels.\",\n      \"method\": \"Gene-trap mouse knockout, Western blot, qRT-PCR, embryo staging\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined embryonic lethal phenotype, directly establishing essential developmental role\",\n      \"pmids\": [\"20393889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HSPD1 (HSP60) interacts with IRF3 and facilitates interferon-beta induction. HSPD1 overexpression promotes IRF3 phosphorylation and dimerization and enhances IFN-β production upon SeV infection; HSPD1 knockdown inhibits this pathway. HSPD1 acts upstream of IRF3 phosphorylation (it does not enhance activity of constitutively active IRF3/5D).\",\n      \"method\": \"Co-immunoprecipitation, overexpression and siRNA knockdown, luciferase reporter assays, SeV infection, Western blot for IRF3 phosphorylation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus epistasis (no effect on pre-phosphorylated IRF3), single lab, multiple methods\",\n      \"pmids\": [\"25506707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FUS physically interacts with HSP60, and FUS translocation to mitochondria is mediated at least in part by HSP60. Downregulating HSP60 in Drosophila reduces mitochondrially localized FUS and partially rescues mitochondrial defects and neurodegenerative phenotypes caused by FUS overexpression.\",\n      \"method\": \"Biochemical interaction assays (Co-IP), Drosophila genetic model with HSP60 knockdown, mitochondrial fractionation, neurodegenerative phenotype assessment\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus genetic epistasis in Drosophila model, single lab\",\n      \"pmids\": [\"26335776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gold(III) meso-tetraphenylporphyrin (gold-1a) directly targets HSP60 and inhibits its chaperonin refolding activity. Multiple chemical biology approaches (photo-affinity labeling, click chemistry, chemical proteomics, cellular thermal shift assay, STD-NMR, protein fluorescence quenching, chaperone assays) established HSP60 as the direct molecular target of the compound both in vitro and in cells.\",\n      \"method\": \"Photo-affinity labeling, click chemistry, chemical proteomics, cellular thermal shift assay, saturation-transfer difference NMR, protein fluorescence quenching, protein chaperone refolding assays\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biophysical and biochemical methods in one study establishing direct target engagement and functional inhibition\",\n      \"pmids\": [\"26663758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Myrtucommulone A (MC) directly binds HSP60 and inhibits its chaperonin refolding activity. MC prevents HSP60-mediated reactivation of denatured malate dehydrogenase. HSP60 inhibition by MC causes aggregation of Lon protease (LONP) and LRP130 in isolated mitochondria under heat shock.\",\n      \"method\": \"Protein fishing/pulldown with MC as bait from mitochondrial lysates, in vitro protein refolding assay (malate dehydrogenase), 2D gel electrophoresis identification of aggregating proteins\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro refolding assay and affinity-based target identification, single lab, multiple methods\",\n      \"pmids\": [\"28457707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mammalian HSP60 possesses GTPase activity in addition to ATPase activity. The presence of GTP differently affects HSP60 allostery, complex formation with HSP10, and protein folding activity compared to ATP. GTP slightly affects the ATPase activity of HSP60 during protein folding.\",\n      \"method\": \"In vitro nucleotide hydrolysis assays, HSP60/HSP10 complex formation assays, protein refolding assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — novel enzymatic activity (GTPase) demonstrated in vitro, single lab, single study\",\n      \"pmids\": [\"29208924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mammalian HSP60 exists predominantly as single-ring heptamers in the absence of co-chaperonin HSP10. In the presence of ATP and HSP10, HSP60 forms mainly football-type double-ring complexes and mediates substrate refolding. After ATP hydrolysis to ADP, HSP60 releases HSP10 and double rings dissociate to single rings. This ATP-dependent single-ring/double-ring transition is distinct from the GroEL/GroES bacterial cycle.\",\n      \"method\": \"Transmission electron microscopy, native PAGE, gel filtration, in vitro refolding assay with purified porcine HSP60\",\n      \"journal\": \"Archives of biochemistry and biophysics / International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal structural and biochemical methods with purified protein establishing distinct mammalian chaperonin cycle mechanism\",\n      \"pmids\": [\"26427351\", \"29415503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structure of human mitochondrial HSPD1 in the apo state reveals that, unlike bacterial GroEL, HSPD1 forms mostly single-ring assemblies in the absence of co-chaperonin HSPE1. Comparison with GroEL shows rotation and increased flexibility of the apical domain in HSPD1.\",\n      \"method\": \"Cryo-electron microscopy (cryo-EM) structural determination\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution cryo-EM structure directly revealing single-ring architecture and domain differences from GroEL\",\n      \"pmids\": [\"33506187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"HSP60 (chaperonin) physically associates with p21ras in mammalian cells. This interaction was detected by chemical cross-linking and verified as physiological by showing that the amount of HSP60 complexed with p21ras did not change upon overexpression of p21ras.\",\n      \"method\": \"Chemical cross-linking, co-immunoprecipitation, protein purification, partial amino acid sequencing, cDNA cloning\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single cross-linking/Co-IP method, single lab; functional significance of interaction not established\",\n      \"pmids\": [\"1347942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with YB-1 at the YB-NLS region in the cytoplasm. Suppression of HSP60 expression increases polysome-associated YB-1 in heavy-sedimenting fractions. Overexpression of HSP60 decreases YB-1 in heavy-sedimenting fractions and suppresses YB-NLS nuclear localization signal activity. Thus HSP60 acts as a regulator of YB-1 polysome association and subcellular distribution.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient sedimentation, overexpression and siRNA knockdown, nuclear localization assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping plus functional gain/loss showing effect on YB-1 distribution, single lab\",\n      \"pmids\": [\"19470374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Extracellular HSP60 binds to the surface of antigen-presenting cells (macrophages and dendritic cells, but not T or B lymphocytes) and co-localizes with LPS co-receptor CD14. HSP60 specifically binds bacterial LPS and synergistically enhances IL-12p40 production and IFN-γ release in T cells in combination with LPS. HSP60 also induces IFN-α production in professional APC, independently of LPS.\",\n      \"method\": \"Binding assays (flow cytometry), co-localization microscopy, cytokine ELISA, IFN-α neutralization, IFN receptor knockout cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assays and receptor-KO controls, multiple cytokine readouts, single lab\",\n      \"pmids\": [\"17164250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arsenic trioxide (ATO) directly binds HSP60 and abolishes its refolding capability. ATO binding to HSP60 disrupts HSP60-p53 and HSP60-survivin complexes, resulting in degradation of p53 and survivin in APL cells.\",\n      \"method\": \"Organoarsenic affinity probe (metalloproteomics), quantitative proteomics, cellular thermal shift assay, biophysical binding assays, cell-based apoptosis assays\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal chemical biology and biophysical methods establishing direct target binding and mechanistic consequence (disruption of HSP60-p53 and HSP60-survivin complexes)\",\n      \"pmids\": [\"34476069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HSPD1 knockdown or chemical disruption by KHS101 induces a drastic breakdown of oxidative phosphorylation and suppresses NSCLC cell proliferation in vitro and in vivo. HSPD1-targeted anti-cancer effects are dependent on oxidative phosphorylation, with creatine-transporter SLC6A8 and cytochrome c oxidase subunit COX5B identified as molecular determinants of sensitivity.\",\n      \"method\": \"CRISPR/Cas9 knockout, siRNA knockdown, extracellular metabolic flux analysis (Seahorse), whole-genome CRISPR screen, drug profiling, transcriptomics, in vivo xenograft\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO plus metabolic flux analysis plus genome-wide screen identifying pathway dependence, replicated in vitro and in vivo\",\n      \"pmids\": [\"34364401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HSP60 (HSPD1) knockdown in renal tubular cells increases intracellular protein aggregates, alters intracellular ATP production (increases ATP), and markedly increases oxidized proteins (under normoglycemic conditions). Under hyperglycemia, HSP60 levels increase and regulate oxidative stress responses, indicating HSP60 is a central node in protein quality control in renal tubular cells.\",\n      \"method\": \"siRNA knockdown, protein aggregation assay, luciferin-luciferase ATP assay, OxyBlot oxidized protein assay, global protein network analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with multiple functional readouts (aggregation, ATP, oxidative stress), single lab\",\n      \"pmids\": [\"28196897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-382 targets HSPD1 (HSP60) mRNA, reducing HSP60 protein levels, which contributes to redox imbalance and renal tubulointerstitial fibrosis. HSPD1 overexpression restores thioredoxin (Trx) expression and reverses TGF-β1-induced loss of E-cadherin; direct siRNA knockdown of HSPD1 in vivo promotes oxidative stress.\",\n      \"method\": \"miR-382 anti-miRNA treatment in UUO mouse model, siRNA knockdown in vivo, HSPD1 overexpression in vitro, luciferase 3'UTR reporter (implied), Western blot, oxidative stress markers\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro functional experiments with HSPD1 manipulation, single lab\",\n      \"pmids\": [\"28680529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Decreased expression of mitochondrial proteases Lon and ClpP is observed in SPG13 patient cells expressing HSP60(p.V98I), at both RNA and protein levels. This is proposed as a cellular adaptation to reduced chaperonin activity that allows more folding attempts for substrate proteins.\",\n      \"method\": \"Lymphoblastoid and fibroblast cells from SPG13 patient, qRT-PCR, Western blot, mitochondrial membrane potential assay, cell viability assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative patient cell data with indirect mechanistic implication; compensatory protease downregulation observed but causal mechanism not directly tested\",\n      \"pmids\": [\"18378094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"c-MYC directly activates HSP60 transcription by binding an E-box (CACGTG) site in the proximal HSP60 promoter. siRNA-mediated repression of HSP60 reduces c-MYC-induced cellular transformation.\",\n      \"method\": \"Promoter luciferase reporter assay, chromatin immunoprecipitation (implied), siRNA knockdown, focus formation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter with E-box mutant and epistasis (HSP60 KD rescues c-MYC transformation), single lab\",\n      \"pmids\": [\"19022255\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPD1 (HSP60) is a mitochondrial chaperonin that forms heptameric single rings (in mammals) or double-ring tetradecamers (in bacteria) and, together with co-chaperonin HSP10/GroES, uses ATP binding and hydrolysis to encapsulate non-native polypeptides in a folding cavity and promote their refolding; mammalian HSP60 undergoes an ATP-dependent single-ring to football-type double-ring transition distinct from the bacterial GroEL cycle, requires existing assembled complex for its own subunit assembly, and is essential for embryonic development. Beyond mitochondrial proteostasis, cytosolic and extracellular HSP60 interacts with survivin and p53 to regulate apoptosis, with beta-catenin to promote metastasis, with IRF3 to facilitate interferon-beta induction, and with Bax/Bak to modulate the apoptotic threshold; mutations in HSPD1 that reduce ATPase and refolding activity cause hereditary spastic paraplegia (SPG13).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HSPD1 (HSP60) is a mitochondrial chaperonin that uses ATP binding and hydrolysis, together with the co-chaperonin HSP10, to encapsulate non-native polypeptides and promote their refolding [#0, #17]. Mammalian HSP60 differs mechanistically from bacterial GroEL: cryo-EM and biochemical reconstitution show it exists predominantly as single-ring heptamers in the apo state and transitions to football-type double-ring complexes upon ATP and HSP10 binding, dissociating back to single rings after ATP hydrolysis [#17, #18], and it possesses GTPase as well as ATPase activity [#16]. Assembly of newly imported HSP60 subunits into oligomeric complexes is itself catalyzed by pre-existing functional HSP60 in an ATP-dependent manner [#1]. Functionally, HSP60 is required to fold mitochondrial clients including manganese superoxide dismutase, and its loss elevates oxidative stress and protein aggregation, defining it as a central node of mitochondrial protein quality control [#10, #24]. HSP60 is essential for early mouse embryonic development [#11], and missense mutations (V72I/V98I) that reduce its ATPase and refolding activity cause SPG13 hereditary spastic paraplegia [#2, #6]. Beyond mitochondrial proteostasis, cytosolic and extracellular pools of HSP60 modulate apoptosis by stabilizing mitochondrial survivin and restraining p53 [#4], promote tumor cell metastasis through beta-catenin [#7], and facilitate interferon-beta induction via IRF3 [#12]. Multiple small molecules (gold-1a, myrtucommulone A, arsenic trioxide, KHS101) directly bind HSP60 and inhibit its refolding activity, and HSPD1 supports cancer cell oxidative phosphorylation and proliferation [#14, #22, #23].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Established that HSP60 oligomer assembly is autocatalytic, addressing how imported subunits acquire their functional double-ring architecture.\",\n      \"evidence\": \"Yeast mif4 mutant with in vitro mitochondrial import and pulse-chase subunit assembly analysis\",\n      \"pmids\": [\"1978929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural intermediate of assembly\", \"Mammalian assembly pathway not directly tested\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"First report that cytosolic/mitochondrial HSP60 physically associates with a signaling GTPase (p21ras), an early hint of roles beyond canonical folding.\",\n      \"evidence\": \"Chemical cross-linking and Co-IP in mammalian cells\",\n      \"pmids\": [\"1347942\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single cross-linking/Co-IP method without reciprocal validation\", \"Functional significance of the interaction not established\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the chaperonin reaction cycle mechanistically, showing how ATP and GroES drive encapsulation and timed release of folding substrates.\",\n      \"evidence\": \"Crystal structures of GroEL-GroES complexes plus in vitro ATPase and folding assays\",\n      \"pmids\": [\"9759498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Based on bacterial GroEL; mammalian HSP60 cycle differences not yet defined\", \"Native substrate repertoire not characterized\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked HSPD1 to a human Mendelian disease, showing a missense mutation impairs essential chaperonin function.\",\n      \"evidence\": \"Family linkage mapping and E. coli groES/groEL complementation assay of wild-type vs V72I HSP60\",\n      \"pmids\": [\"11898127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not quantify the biochemical defect of the mutant\", \"Neuronal pathophysiology not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended HSP60 function to apoptosis regulation and to interaction with the mortalin chaperone, indicating cytosolic and cross-chaperone roles.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, siRNA knockdown and microscopy in cardiac and tumor cells\",\n      \"pmids\": [\"15784164\", \"15957980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without structural mapping of Bax/Bak binding\", \"Mechanism of hypoxia-induced redistribution unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed HSP60 stabilizes mitochondrial survivin and restrains p53, defining a cyto-protective apoptotic node in tumor cells, and identified a non-classical exosomal secretion route.\",\n      \"evidence\": \"siRNA ablation with reciprocal Co-IP, apoptosis flow cytometry, and exosome fractionation\",\n      \"pmids\": [\"18086682\", \"17307989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether survivin/p53 binding is direct or chaperone-mediated unclear\", \"Trigger for exosomal release not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved the molecular basis of SPG13 by showing the V98I mutation reduces ATPase and refolding activity and acts dominant-negatively.\",\n      \"evidence\": \"In vitro ATPase and malate dehydrogenase refolding assays plus bacterial conditional-expression model; patient-cell protease expression analysis\",\n      \"pmids\": [\"18400758\", \"18378094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory Lon/ClpP downregulation is correlative (Low confidence)\", \"Link from folding defect to motor neuron degeneration not mechanistically traced\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified an upstream transcriptional driver, showing c-MYC activates HSP60 to support oncogenic transformation.\",\n      \"evidence\": \"E-box promoter luciferase reporter, ChIP, and siRNA rescue of focus formation\",\n      \"pmids\": [\"19022255\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Other transcriptional inputs not mapped\", \"Single-lab evidence\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Broadened cytosolic HSP60 functions to beta-catenin-driven metastasis and YB-1 distribution control.\",\n      \"evidence\": \"Co-IP with domain mapping, overexpression/siDNA epistasis, invasion and mouse metastasis assays; sucrose-gradient analysis of YB-1\",\n      \"pmids\": [\"19369584\", \"19470374\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of proteasome-independent beta-catenin stabilization unresolved\", \"Single-lab Co-IPs\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established HSP60 as essential for early mammalian development through clean genetic ablation.\",\n      \"evidence\": \"Gene-trap homozygous Hspd1 knockout mice with embryo staging\",\n      \"pmids\": [\"20393889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific lethal cellular defect not identified\", \"Tissue-specific roles not dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected HSP60 chaperone activity to redox homeostasis via MnSOD folding and defined extracellular HSP60 as a TLR4 inflammatory ligand.\",\n      \"evidence\": \"Heterozygous Hspd1 KO mice with Hsp60-MnSOD Co-IP and oxidative stress assays; exogenous HSP60 with pathway inhibitors and rat LAD ligation\",\n      \"pmids\": [\"24151936\", \"23447644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MnSOD misfolding fully explains neuronal oxidative stress untested\", \"Receptor specificity of secreted HSP60 vs endotoxin contamination concern\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed HSP60 in innate antiviral signaling upstream of IRF3 phosphorylation.\",\n      \"evidence\": \"Co-IP, gain/loss of function, IFN-beta reporter and SeV infection, with epistasis against constitutively active IRF3\",\n      \"pmids\": [\"25506707\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic role in IRF3 activation not defined\", \"Single-lab evidence\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Implicated HSP60 in mitochondrial trafficking of the disease protein FUS, linking it to neurodegeneration models.\",\n      \"evidence\": \"Co-IP and Drosophila genetic knockdown with mitochondrial fractionation and phenotype rescue\",\n      \"pmids\": [\"26335776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HSP60 directly imports FUS or chaperones it is unresolved\", \"Mammalian relevance not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Refined the mammalian chaperonin cycle and revealed an intrinsic GTPase activity, distinguishing HSP60 from GroEL.\",\n      \"evidence\": \"TEM, native PAGE, gel filtration and refolding assays with purified porcine HSP60; in vitro nucleotide hydrolysis assays\",\n      \"pmids\": [\"26427351\", \"29415503\", \"29208924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of GTPase activity in cells untested\", \"Structural basis of the single/double-ring switch not resolved here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined HSP60 as a central protein-quality-control node in renal tubular cells under metabolic stress.\",\n      \"evidence\": \"siRNA knockdown with aggregation, ATP, and oxidized-protein assays; miR-382/HSPD1 manipulation in UUO mouse model\",\n      \"pmids\": [\"28196897\", \"28680529\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct client proteins driving aggregation not identified\", \"Single-lab in vivo data\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided high-resolution structural confirmation that human HSPD1 adopts single-ring architecture distinct from GroEL.\",\n      \"evidence\": \"Cryo-EM structure of apo human HSPD1\",\n      \"pmids\": [\"33506187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate-bound and HSP10-bound states not resolved in this work\", \"Functional consequence of apical-domain flexibility untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Validated HSP60 as a druggable target whose inhibition disrupts apoptotic complexes and oxidative phosphorylation in cancer.\",\n      \"evidence\": \"Metalloproteomic and chemical-probe target ID (arsenic trioxide), CRISPR/siRNA with Seahorse flux and genome-wide screen (KHS101) in NSCLC and APL\",\n      \"pmids\": [\"34476069\", \"34364401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity of inhibitors over other chaperones incompletely defined\", \"Mechanistic link between OXPHOS collapse and HSP60 folding clients not fully mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the mammalian single-ring/double-ring cycle and GTPase activity select and process specific endogenous mitochondrial clients, and how moonlighting cytosolic/extracellular HSP60 functions mechanistically relate to its chaperonin activity, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No comprehensive endogenous substrate map\", \"Direct vs chaperone-mediated nature of cytosolic interactions unresolved\", \"Structural basis of GTP-dependent allostery undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 17, 18]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1, 6, 16, 17]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [10, 15, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 10, 15, 18, 24]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 7, 20]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [3, 8, 21]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 10, 17, 24]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 12, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 6, 23]}\n    ],\n    \"complexes\": [\n      \"HSP60/HSP10 (HSPD1/HSPE1) chaperonin\"\n    ],\n    \"partners\": [\n      \"HSPE1\",\n      \"HSPA9\",\n      \"TP53\",\n      \"BIRC5\",\n      \"CTNNB1\",\n      \"IRF3\",\n      \"FUS\",\n      \"SOD2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}